Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma
Gardner, Heather L, Rippy, Sarah B, Bear, Misty D, Cronin, Kim L, Heeb, Heather, Burr, Holly, Cannon, Claire M, Penmetsa, Kumar V, Viswanadha, Srikant, Vakkalanka, Swaroop, London, Cheryl A
Published in PloS one (24.04.2018)
Published in PloS one (24.04.2018)
Get full text
Journal Article
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
Rippy, Sarah B, Gardner, Heather L, Nguyen, Sandra M, Warry, Emma E, Portela, Roberta A, Drost, William Tod, Hostnik, Eric T, Green, Eric M, Chew, Dennis J, Peng, Juan, London, Cheryl A
Published in BMC veterinary research (17.11.2016)
Published in BMC veterinary research (17.11.2016)
Get full text
Journal Article
Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
Rippy, Sarah B, Gardner, Heather L, Nguyen, Sandra M, Warry, Emma E, Portela, Roberta F, Drost, William Tod, Hostnik, Eric T, Green, Eric M, Chew, Dennis J, Peng, Juan, London, Cheryl A
Published in BMC veterinary research (30.12.2016)
Published in BMC veterinary research (30.12.2016)
Get full text
Journal Article
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells
London, Cheryl A, Gardner, Heather L, Rippy, Sarah, Post, Gerald, La Perle, Krista, Crew, Linda, Lopresti-Morrow, Lori, Garton, Andrew J, McMahon, Gerald, LaVallee, Theresa M, Gedrich, Richard
Published in Clinical cancer research (15.05.2017)
Published in Clinical cancer research (15.05.2017)
Get full text
Journal Article
Phase I/II evaluation of RV1001, a novel PI3K[delta] inhibitor, in spontaneous canine lymphoma
Gardner, Heather L, Rippy, Sarah B, Bear, Misty D, Cronin, Kim L, Heeb, Heather, Burr, Holly, Cannon, Claire M, Penmetsa, Kumar V, Viswanadha, Srikant, Vakkalanka, Swaroop, London, Cheryl A
Published in PloS one (24.04.2018)
Published in PloS one (24.04.2018)
Get full text
Journal Article
Abstract C167: KTN0158, a humanized anti-KIT monoclonal antibody, demonstrates antitumor activity in dogs with mast cell tumors
London, Cheryl, Rippy, Sarah, Gardner, Heather, Kisseberth, William, Post, Gerald, Janson, Neal, Crew, Linda, LaVallee, Theresa, Gedrich, Richard
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
Abstract 4700: The novel and selective PI3Kδ inhibitor, RV1001, displays single agent biologic activity in spontaneous canine NHL
London, Cheryl A., Rippy, Sarah B., Bear, Misty D., Cronin, Kim, Abbo, Andrew H., Penmetsa, Kumar V., Viswanadha, Srikant, Vakkalanka, Swaroop
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 4409: STA-12-8666: a first-in-class HSP90 inhibitor drug conjugate (HDC) designed to selectively deliver chemotherapy to tumors
Proia, David A., Smith, Donald L., Zhang, Junyi, Zhou, Dan, Jimenez, John-Paul, Sang, Jim, Rippy, Sarah, London, Cheryl, Ogawa, Luisa S., Jiang, Jun, Przewloka, Teresa, Sequeira, Manuel, Acquaviva, Jaime, He, Suqin, Chu, John, Zhang, Chaohua, Liu, Yuan, Ye, Josephine, Khazak, Vladimir, Astsaturov, Igor, Inoue, Takayo, Tatsuta, Noriaki, Bates, Richard C., Sonderfan, Andrew, Chimmanamada, Dinesh, Ying, Weiwen
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article